Acad. Sci. USA 74, 764-7681 on the purification and characterization of the DNA polymerase from human breast cancer particles. Its preference for certain synthetic templates and its ability to use a viral RNA to fashion a faithful DNA transcript identify it as a reverse transcriptase similar to that found in the mouse mammary tumor virus and in the Mason-Pfizer monkey virus (MPMV). We report here that the human breast cancer enzyme crossreacts immunologically with the reverse transcriptase of MPMV. The crossreactivity was shown both by inhibition of enzyme activity and by complex formation between purified enzyme and isolated IgG against MPMV polymerase. No such interactions were observed with other oncornavirus reverse transcriptases of avian, murine, feline, or simian origin. Further, the IgG failed to neutralize the reverse transcriptases from human mesenchymal neoplasias (leukemias and lymphomas) or the activities of normal cellular DNA polymerases (a, A, y).Previous studies (1-7) have identified human breast tumor particles that exhibit many of the features characteristic of RNA tumor viruses. In addition to the expected size (600 S) and density (1.16 g/ml), these particles have an outer membrane and an inner one surrounding a "core" containing a DNA polymerase (deoxynucleosidetriphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.7) (reverse transcriptase) complexed to a large (70 S) RNA exhibiting detectable homology to the RNAs of the mouse mammary tumor virus and of the Mason-Pfizer monkey virus (MPMV). The DNA polymerase of human breast cancer particles has been purified (8) as a 70,000-dalton protein with the following three features that together serve to distinguish viral reverse transcriptases from the known animal cellular DNA polymerases: (i) a strong preference for oligo(dT)-poly(rA) over oligo(dT)-poly(dA) as a template for the synthesis of poly(dT); (ii) the acceptance of the specific oligo(dG)-poly(rCm) as a template for the synthesis of poly(dG); and (iii) the ability to use a viral RNA (avian myeloblastosis virus) as a template to fashion a faithful DNA complementary copy.The present investigation focuses on the antigenic properties of the human breast cancer reverse transcriptase with particular emphasis on possible crossreactivities with animal viral reverse transcriptases. This type of immunologic information has been used by tumor virologists to classify the oncogenic RNA viruses into the following distinct groups: (i) the avian leukemia-sarcoma viruses (9-11); (ii) the subprimate leukemia-sarcoma viruses (9-14); (iii) the nonhuman primate leukemia-sarcoma viruses (11,13,14); (iv) the mouse mammary tumor virus (9, 10, 12); and (v) a unique group composed of the MPMV and its close relatives (15).In addition to its biologic and evolutionary implications, the identification of antigenic relationships among oncogenic agents from different species can generate useful immunologic reagents for the detection of viruses or their protein components. In particular, a demonstration of an antigenic ...